Kawasaki disease or Kawasaki‐like disease: Influence of SARS‐CoV‐2 infections in Japan-Reference-Cited by-同舟云学术

Kawasaki disease or Kawasaki‐like disease: Influence of SARS‐CoV‐2 infections in Japan

Published:2020-10-13 Issue:2 Volume:110 Page:600-601
ISSN:0803-5253
Container-title:Acta Paediatrica
language:en
Short-container-title:Acta Paediatr

Author:

Iio Kazuki¹^ORCID,Uda Kazuhiro²,Hataya Hiroshi¹,Yasui Fumihiko³,Honda Tomoko³,Sanada Takahiro³,Yamaji Kenzaburo³,Kohara Michinori³,Itokawa Masanari⁴,Miura Masaru⁵

Affiliation:

1. Department of General Pediatrics Tokyo Metropolitan Children’s Medical Center Fuchu Japan

2. Department of Infectious Diseases Tokyo Metropolitan Children’s Medical Center Fuchu Japan

3. Department of Microbiology and Cell Biology Tokyo Metropolitan Institute of Medical Science Setagaya Japan

4. Center for Medical Research Cooperation Tokyo Metropolitan Institute of Medical Science Setagaya Japan

5. Department of Cardiology Tokyo Metropolitan Children’s Medical Center Fuchu Japan

Publisher

Wiley

Subject

General Medicine,Pediatrics, Perinatology and Child Health

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/apa.15535

Reference5 articles.

1. Clinical Characteristics of 58 Children With a Pediatric Inflammatory Multisystem Syndrome Temporally Associated With SARS-CoV-2

2. Multisystem Inflammatory Syndrome in U.S. Children and Adolescents

3. Patient Age and the Seasonal Pattern of Onset of Kawasaki’s Disease

4. Recognition of a Kawasaki Disease Shock Syndrome

5. Analysis of serologic cross‐reactivity between common human coronaviruses and SARS‐CoV‐2 Using coronavirus antigen microarray;Khan S;bioRxiv,2020

Cited by 22 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Multisystem Inflammatory Syndrome in Children (MIS-C) in a Lowincome Country: What Treatment Should be Adopted in Case of a Lack of Immunoglobulin?;Reviews on Recent Clinical Trials;2023-12-26

2. Serological analysis of severe acute respiratory syndrome coronavirus 2 infection in children with Kawasaki disease;Journal of Medical Virology;2023-11

3. Integrative single‐cell transcriptome analysis provides new insights into post‐COVID‐19 pulmonary fibrosis and potential therapeutic targets;Journal of Medical Virology;2023-11

4. Kawasaki disease following SARS-CoV-2 infection: Stronger inflammation with no increase in cardiac complications;Frontiers in Pediatrics;2022-11-17

5. Ultrasound Comparative Analysis of Coronary Arteries before and after Immune Blocking Therapy with Gamma Globulin in Children with Kawasaki Disease;Evidence-Based Complementary and Alternative Medicine;2022-08-04